In order to move cancer studies rapidly forward, we innovate by funding comparative oncology research. We believe that studying naturally-occurring canine cancer holds the key to curing the disease in people and pets.
We invest in gifted scientists with proven track records in cancer research who focus on comparative oncology, awarding two-year grants for projects that focus on increasing the scientific knowledge of cancer, developing new and improved therapies for pets and people, and establishing proof-of-concept to enable these groundbreaking projects to attract additional funds.